Total Payments
$961.50
2024 Payments
$611.53
Companies
18
Transactions
28
Medicare Patients
290
Medicare Billing
$14,449
Payment Breakdown by Category
Food & Beverage$961.50 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $961.50 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sirtex Medical Inc | $142.16 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $123.37 | 1 | $0 (2024) |
| Mirati Therapeutics, Inc. | $115.09 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $85.93 | 3 | $0 (2024) |
| Tempus AI, Inc | $66.44 | 1 | $0 (2024) |
| Celgene Corporation | $58.79 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $54.88 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $49.94 | 3 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $42.42 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $42.24 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $611.53 | 17 | Sirtex Medical Inc ($142.16) |
| 2023 | $266.92 | 7 | Mirati Therapeutics, Inc. ($115.09) |
| 2022 | $44.71 | 2 | JAZZ PHARMACEUTICALS INC. ($23.49) |
| 2021 | $24.73 | 1 | GENZYME CORPORATION ($24.73) |
| 2019 | $13.61 | 1 | Novartis Pharmaceuticals Corporation ($13.61) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $123.37 | General |
| 10/24/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $66.44 | General |
| 10/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Oncology | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.88 | General |
| 06/03/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 05/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.96 | General |
| 04/30/2024 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 04/10/2024 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $142.16 | General |
| Category: Interventional Oncology | ||||||
| 11/29/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Oncology | ||||||
| 11/16/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Oncology | ||||||
| 10/05/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.67 | General |
| Category: Hematology | ||||||
| 10/02/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/29/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $115.09 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.09 | General |
| 08/24/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $41.12 | General |
| Category: Hematology | ||||||
| 09/29/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 234 | 490 | $64,393 | $10,150 |
| 2022 | 1 | 13 | 13 | $1,846 | $711.09 |
| 2021 | 1 | 13 | 13 | $1,846 | $683.56 |
| 2020 | 2 | 30 | 46 | $8,243 | $2,905 |
Total Patients
290
Total Services
562
Medicare Billing
$14,449
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 30 | 42 | $29,694 | $4,135 | 13.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $6,944 | $1,709 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $4,048 | $975.00 | 24.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 15 | $4,695 | $724.20 | 15.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 24 | 55 | $5,940 | $642.94 | 10.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 13 | 24 | $3,768 | $525.68 | 14.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 15 | $2,415 | $320.14 | 13.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 28 | $2,688 | $301.56 | 11.2% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 11 | 12 | $1,368 | $230.28 | 16.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 30 | $600.00 | $228.12 | 38.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 16 | 17 | $1,088 | $166.82 | 15.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 19 | 24 | $864.00 | $162.51 | 18.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 190 | $190.00 | $18.65 | 9.8% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 11 | 13 | $91.00 | $9.51 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 13 | $1,846 | $711.09 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 13 | $1,846 | $683.56 | 37.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 29 | $5,829 | $2,346 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 17 | 17 | $2,414 | $559.46 | 23.2% |
About Jasmine Gowarty
Jasmine Gowarty is a Internal Medicine healthcare provider based in Mcallen, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1003263732.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jasmine Gowarty has received a total of $961.50 in payments from pharmaceutical and medical device companies, with $611.53 received in 2024. These payments were reported across 28 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($961.50).
As a Medicare-enrolled provider, Gowarty has provided services to 290 Medicare beneficiaries, totaling 562 services with total Medicare billing of $14,449. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Mcallen, TX
- Active Since 05/23/2016
- Last Updated 10/03/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003263732
Products in Payments
- SIR-Spheres Microspheres (Device) $142.16
- KRAZATI (Drug) $115.09
- Enhertu (Drug) $49.94
- XPOVIO (Drug) $42.42
- DIFICID (Drug) $42.24
- Pomalyst (Drug) $41.12
- OJJAARA (Drug) $40.86
- JEVTANA (Drug) $24.73
- PROMACTA (Drug) $24.27
- DEFITELIO (Drug) $23.49
- OSTEOCOOL RF ABLATION SYSTEM (Device) $23.46
- RYBREVANT (Drug) $19.89
- LIBTAYO (Biological) $18.02
- REBLOZYL (Biological) $17.67
- KISQALI (Drug) $17.00
- BAVENCIO (Drug) $16.66
- TASIGNA (Drug) $13.61
- FOTIVDA (Drug) $13.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mcallen
Dr. Luis Rosas, M.d, M.D
Internal Medicine — Payments: $102,721
Internal Medicine $102,721
Dr. Carlos Giraldo, Md, MD
Internal Medicine — Payments: $95,900
Internal Medicine $95,900
Roberto Cruz Saldana, M.d, M.D
Internal Medicine — Payments: $52,911
Internal Medicine $52,911
Rashmee Patil
Internal Medicine — Payments: $45,994
Internal Medicine $45,994
Dr. Raghad Abdul-Karim, Md, MD
Internal Medicine — Payments: $35,140
Internal Medicine $35,140
Federico Azpurua, Md, MD
Internal Medicine — Payments: $20,451
Internal Medicine $20,451